首页> 美国卫生研究院文献>Clinical and Applied Thrombosis/Hemostasis >Relationship Between Severity of Fibrinolysis Based on Rotational Thromboelastometry and Conventional Fibrinolysis Markers
【2h】

Relationship Between Severity of Fibrinolysis Based on Rotational Thromboelastometry and Conventional Fibrinolysis Markers

机译:基于旋转血管血管抑制法和常规纤维蛋白解标记分析纤维蛋白溶解度的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The association between severity of fibrinolysis, ascertained by rotational thromboelastometry to diagnose hyperfibrinolysis in patients with out-of-hospital cardiac arrest (OHCA), and conventional fibrinolysis markers (ie, tissue-plasminogen activator [t-PA], plasminogen, α2-plasmin inhibitor [α2-PI], and plasminogen activator inhibitor [PAI]) with key roles in the fibrinolytic system was investigated. This prospective observational study included 5 healthy volunteers and 35 patients with OHCA from the Hokkaido University Hospital. Blood samples were drawn immediately upon admission to the emergency department. Assessments of the extrinsic pathway using tissue factor activation (EXTEM) and of fibrinolysis by comparison with EXTEM after aprotinin addition (APTEM) were undertaken. Conventional coagulation and fibrinolysis markers were measured in the stored plasma samples. Significant hyperfibrinolysis observed in EXTEM disappeared in APTEM. Patients exhibited significantly higher levels of fibrinogen/fibrin degradation products, plasmin–α2-PI complex, and t-PA but lower levels of fibrinogen, plasminogen, and α2-PI than healthy controls. The PAI level was unchanged. Fibrinolytic parameters of EXTEM correlated with levels of lactate and conventional fibrinolysis markers, especially t-PA. Increased t-PA activity and decreased plasminogen and α2-PI significantly correlated with increased severity of fibrinolysis (hyperfibrinolysis).
机译:纤维蛋白溶解度的严重程度之间的关联,通过旋转血管血管抑制测定术治疗患者患者患者患者,以及常规纤维蛋白溶解标记物(即组织 - 纤溶酶原激活剂[T-PA],纤溶酶原,α2-纤溶酶研究了纤维蛋白溶解系统中具有关键作用的抑制剂[α2-PI]和纤溶酶原激活剂抑制剂[PAI]。该预期观察研究包括5名健康志愿者和35名北海道大学医院欧安科省Ohca患者。在入场时立即绘制血样。进行了使用组织因子激活(EXTEM)和纤维蛋白溶解的外部途径的评估,并通过与EXTEM在抑制后(APTEM)进行纤维蛋白溶解。在储存的等离子体样品中测量常规凝血和纤维蛋白溶解标记物。在EXTEM中观察到的显着高纤维蛋白溶解在APTEM中消失了。患者表现出较高水平的纤维蛋白原/纤维蛋白降解产物,纤溶酶-α2-PI复合物和T-PA,但较低的纤维蛋白原,纤溶酶原和α2-PI水平而不是健康对照。 PAI水平没有变化。 EXTEM的纤维蛋白溶解参数与乳酸水平和常规纤维蛋白解标记物相关,尤其是T-PA。增加T-PA活性和降低的纤溶酶原和α2-PI与纤维蛋白溶解的严重程度(高纤维蛋白溶解)显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号